COO and Vice President of Operations/Development
David Gyorke joined Radiance Therapeutics as Chief Operating Officer, Vice President of Operations and Development, in April 2020. Previously, he has served as COO / Sr. VP of Global Manufacturing Operations for Chembio Diagnostics Systems (CEMI; Nasdaq) and V.P. Operations at Nanomix (IVD). He held the position of Vice President, Development and Operations, for Neovista (startup epimacular brachytherapy device company for the treatment of wet AMD). Mr. Gyorke has also held various leadership positions with IVD, neuro access, and ultrasound imaging medical device companies. He received his Bachelor of Science in Industrial Engineering at California Polytechnic State University, San Luis Obispo, and holds patents for epiretinal cannula visible delivery device and neuro-aneurysm coils. He has served on the Boards of Coag-sense and nonprofit Rebuilding Together.